Prevalence of human papillomavirus types in cervical and oral cancers in central India
Abstract
Cervical cancer that is associated with high-risk human papillomaviruses (HPV) is the most common malignancy in Indian women. Therefore, the establishment of a prevention program is urgently required considering both vaccination and screening. However, relatively little is known about the prevalence of the different HPV types in cervical cancers in different regions of India, particularly central India. In this study, we have determined the HPV type distribution in 180 cervical cancers of women from Sevagram, a rural area from central India. In addition, we have analyzed other epithelial cancers that are known to be in part associated with high-risk HPV infection, i.e. oral (n=65), vulva and vagina (n=7) and penis (n=7). Approximately 93% of cervical cancers were positive for one or more of the high-risk HPV types. HPV16 was the predominant type being present in 81.7% of the cases. The remaining most predominant high-risk HPV types were: 18, 31, 35, 45, 56 and 59. Oral and vulva/vagina cancers were exclusively associated with HPV16, 27.7% and 70%, respectively. None of penile cancers was found positive for any of the high-risk HPV types. These data show that HPV16 vaccination in this geographical region will have considerable impact on the prevention of cervical and other epithelial cancers.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
HPV16 alone causes around 63-81% of cervical cancers in the general population and HPV18 accounts for another 10-15% in India.
“Among the oncogenic HPV types, HPV16 alone causes around 63-81% of cervical cancers in the general population and HPV18 accounts for another 10 to 15% in India [3–5].”
From HPV Screening in Women Living with HIV (WLHIV) in Karnataka, India: Can it be Integrated into ART Centres? (2025) · cites this paper as [5]
Nearly all cervical cancers harbour HPV DNA, particularly oncogenic sequences such as E6 and E7.
“Nearly all cervical cancers harbour HPV DNA, particularly oncogenic sequences such as E6 and E7, emphasizing the causal role of persistent HPV infection in cervical carcinogenesis [5, 6].”
From HPV Screening in Women Living with HIV (WLHIV) in Karnataka, India: Can it be Integrated into ART Centres? (2025) · cites this paper as [5]
Cites
Sowjanya, A. P., Jain, M., Poli, U. R., Padma, S., Das, M., Shah, K. V., Rao, B., Devi, R. R., Gravitt, P. E., & Ramakrishna, G. (2005) · BMC Infectious Diseases · doi:10.1186/1471-2334-5-116 · Cited by 155 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Rao, S., R, S., Sarma, D., Nath, A., R, A., Jagannathan, L., Rao, A., Suhas, G., Iyengar, S., V, R., et al. (2025) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2025.26.12.4513
“Nearly all cervical cancers harbour HPV DNA, particularly oncogenic sequences such as E6 and E7, emphasizing the causal role of persistent HPV infection in cervical carcinogenesis [5, 6].”
- Authors
- Gheit, T., Vaccarella, S., Schmitt, M., Pawlita, M., Franceschi, S., Sankaranarayanan, R., Sylla, B. S., Tommasino, M., & Gangane, N.
- Affiliations
- Centre international de recherche sur le cancer (FR)
- German Cancer Research Center (DE)
- Mahatma Gandhi Institute of Medical Sciences (IN)
- Corresponding author
- Tommasino, Massimo
- ORCID
- Venue
- Vaccine
- Publisher
- Elsevier BV
- Published
- 2009-01
- Volume
- 27
- Issue
- 5
- Pages
- 636-639
- ISSN
- 0264-410X (ISSN-L)
- OpenAlex
- W1967878457
- Cited by
- 68
- References
- 1
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 8 · 2023: 7 · 2022: 2 · 2021: 5 · 2020: 6 · 2018: 3 · 2017: 8 · 2016: 2 · 2015: 7 · 2014: 3 · 2013: 4 · 2012: 3
- FWCI
- 1.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Vaccine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Association pour la Recherche sur le Cancer
- Ligue Contre le Cancer
- Topics
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Health Sciences › Medicine › Surgery › Genital Health and Disease
- Keywords
- human papillomavirus, HPV genotype distribution, cervical cancer, oral cancer, vulvar cancer, vaginal cancer, penile cancer, HPV16, high-risk HPV, HPV vaccination, cancer prevention, rural women, Central India
- MeSH terms
- Adult, Aged, Aged, 80 and over, Uterine Cervical Neoplasms, Female, Genotype, Humans, India, Male, Middle Aged, Mouth Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Prevalence, Papillomaviridae, Papillomavirus Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review